Associations of lead biomarkers with renal function in Korean lead workers

Occupational and Environmental Medicine

Volumn 60, Issue 8, 2003, Pages 551-562

  Weaver, V M ^b   Lee, B K ^a   Ahn, K D ^a   Lee, G S ^a   Todd, A C ^c   Stewart, W F ^d   Wen, J ^b   Simon, D J ^d   Parsons, P J ^e   Schwartz, B S ^b  

^a Soonchunhyang University   (South Korea)

^b The Johns Hopkins University   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CADMIUM; CREATININE; LEAD; N ACETYL BETA GLUCOSAMINIDASE; RETINOL BINDING PROTEIN;

ADULT; AGED; ARTICLE; BONE LEVEL; BONE MINERAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ENVIRONMENTAL EXPOSURE; FEMALE; GROUPS BY AGE; HUMAN; KIDNEY FUNCTION; KOREA; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; PRIORITY JOURNAL; PROTEIN URINE LEVEL; UREA NITROGEN BLOOD LEVEL; WORKER;

EID: 0042090349     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.60.8.551     Document Type: Article

References (50)

1. Steenland K, Selevan S, Landrigan P. The mortality of lead smelter workers: an update. Am J Public Health 1992;82:1641-4.
2. Wedeen RP, Mallik DK, Batuman V. Detection and treatment of occupational lead nephropathy. Arch Intern Med 1979;139:53-7.
3. Inglis JA, Henderson DA, Emmerson BT. The pathology and pathogenesis of chronic lead nephropathy occurring in Queensland. J Pathol 1978;124:65-76.
4. Batuman V. Lead nephropathy, gout, and hypertension. Am J Med Sci 1993;305:241-7.
5. Payton M, Hu H, Sparrow D, et al. Low-level lead exposure and renal function in the Normative Aging Study. Am J Epidemiol 1994;140:821-9.
6. Staessen JA, Lauwerys RR, Buchet JP, et al. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med 1992;327:151-6.
7. Kim R, Rotnitzky A, Sparrow D, et al. A longitudinal study of low-level lead exposure and impairment of renal function. JAMA 1996;275:1177-81.
8. Lin JL, Ho HH, Yu CC. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency: a randomized, controlled trial. Ann Intern Med 1999;130:7-13.
9. Lin JL, Tan DT, Hsu KH, et al. Environmental lead exposure and progressive renal insufficiency. Arch Intern Med 2001;161:264-71.
10. Ong CN, Endo G, Chia KS, et al. Evaluation of renal function in workers with low blood lead levels. In: Foa V, ed. Occupational and environmental chemical hazards. New York: Halstead Press, 1987:327-33.
11. Cardozo dos Santos A, Colacciopo S, Dal Bo CMR, et al. Occupational exposure to lead, kidney function tests, and blood pressure. Am J Ind Med 1994;26:635-43.
12. Verschoor M, Wibowo A, Herber R, et al. Influence of occupational low-level lead exposure on renal parameters. Am J Ind Med 1987;12:341-51.
13. Pergande M, Jung K, Precht S, et al. Changed excretion of urinary proteins and enzymes by chronic exposure to lead. Nephrol Dial Transplant 1994;9:613-18.
14. Ramirez-Cervantes B, Embree JW, Hine CH, et al. Health assessment of employees with different body burdens of lead. J Occup Med 1978;20:610-17.
15. Lilis R, Valciukas J, Fischbein A, et al. Renal function impairment in secondary lead smelter workers: correlations with zinc protoporphyrin and blood lead levels. J Environ Pathol Toxicol 1979;2:1447-74.
16. Ehrlich R, Robins T, Jordaan E, et al. Lead absorption and renal dysfunction in a South African battery factory. Occup Environ Med 1998;55:453-60.
17. Omae K, Sokurai H, Higashi T, et al. No adverse effects of lead on renal function in lead-exposed workers. Ind Health 1990;28:77-83.
18. Cardenas A, Roels H, Bernard AM, et al. Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead. Br J Ind Med 1993;50:28-36.
19. Meyer BR, Fischbein A, Rosenman K, et al. Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals. Am J Med 1984;76:989-98.
20. Gerhardsson L, Chettle DR, Englyst V, et al. Kidney effects in long term exposed lead smelter workers. Br J Ind Med 1992;49:186-92.
21. Roels H, Lauwerys R, Konings J, et al. Renal function and hyperfiltration capacity in lead smelter workers with high bone lead. Occup Environ Med 1994;51:505-12.
22. Roels H, Bernard A, Lauwerys R. Urinary N-acetyl-β-D- glucosaminidase (NAG) and exposure to inorganic lead. Occup Environ Med 1995;52:286-7.
23. Hu H. A 50-year follow-up of childhood plumbism. Hypertension, renal function, and hemoglobin levels among survivors. Am J Dis Child 1991;145:681-7.
24. Schwartz BS, Lee BK, Lee GS, et al. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol 2001;153:453-64.
25. Lee BK, Lee GS, Stewart WF, et al. Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ Health Perspect 2001;109:383-9.
26. Kneip TJ, Crable JV. Methods for biological monitoring: a manual for assessing human exposure to hazardous substances. Washington, DC: American Public Health Association, 1988:199-201.
27. 109Cd "spot" source. Basic Life Sci 1993;60:299-302.
28. 109Cd sources: radiation dosimetry studies. Environ Res 1992;57:117-32.
29. Schwartz BS, Stewart WF, Todd AC, et al. Predictors of dimercaptosuccinic acid chelatable lead and tibial lead in former organolead manufacturing workers. Occup Environ Med 1999;56:22-9.
30. Kim R, Aro A, Rotnitzky A, et al. K X-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys Med Biol 1995;40:1475-85.
31. Parsons PJ, Slavin W. Electrothermal atomization atomic absorption spectrometry for the determination of lead in urine: results of an interlaboratory study. Spectrochim Acta Part B 1999;54:853-64.
32. Pruszkowska E, Carnick G, Slavin W. Direct determination of cadmium in urine with use of a stabilized temperature platform furnace and Zeeman background correction. Clin Chem 1983;29:477-80.
33. Hornung RW, Reed LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hygiene 1990;5:46-51.
34. Weaver VM, Buckley TJ, Groopman JD. Lack of specificity of trans,trans-muconic acid as a benzene biomarker after ingestion of sorbic acid preserved foods. Cancer Epidemiol Biomarkers Prevention 2000;9:749-55.
35. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
36. Wallach J. Interpretation of diagnostic tests, 6th edn. Boston: Little, Brown and Co., 1996:83.
37. Yuen CT, Kind PRN, Price RG, et al. Colorimetric assay for N-acetyl-β-D-glucosaminidase (NAG) in pathological urine using the ω-nitrostyryl substrate: the development of a kit and the comparison of manual procedure with the automated fluorimetric method. Ann Clin Biochem 1984;21:295-300.
38. Topping MD, Forster HW, Dolman C, et al. Measurement of urinary retinol-binding protein by enzyme-linked immunosorbent assay, and its application to detection of tubular proteinuria. Clin Chem 1986;32:1863-6.
39. Blumberg WE, Eisinger J, Lamola AA, et al. Zinc protoporphyrin level in blood determined by a portable hematofluorometer: a screening device for lead poisoning. J Lab Clin Med 1977;89:712-23.
40. Oishi H, Nomiyama H, Nomiyama K, et al. Fluorometric HPLC determination of delta-aminolevulinic acid (ALA) in the plasma and urine of lead workers: biological indicators of lead exposure. J Anal Toxicol 1996;20:106-10.
41. Sithisarankul P, Schwartz BS, Lee BK, et al. Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers. Am J Ind Med 1997;32:15-20.
42. Kleinbaum DG, Kupper LL, Muller KE, et al. Applied regression analysis and other multivariable methods, 3rd edn. Pacific Grove, CA: Brooks/Cole Publishing Company, 1998:224-7.
43. Weisberg S. Applied linear regression. New York: John Wiley & Sons, 1985:52-3.
44. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979;74:829-36.
45. Khalil-Manesh F, Gonick HC, Cohen AH, et al. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int 1992;41:1192-203.
46. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 1996;49:1774-7.
47. Allon R. Renal abnormalities in sickle cell disease. Arch Intern Med 1990;150:501-4.
48. Nenov VD, Taal MW, Sakharova OV, et al. Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hyper 2000;9:85-97.
49. Bernard A, Thielemans N, Roels H, et al. Association between NAG-B and cadmium in urine with no evidence of a threshold. Occup Environ Med 1995;52:177-80.
50. Buchet JP, Lauwerys R, Roels H, et al. Renal effects of cadmium body burden of the general population. Lancet 1990;336:699-702.